DLC1: A significant GAP in the cancer genome Journal Article


Authors: Lahoz, A.; Hall, A.
Article Title: DLC1: A significant GAP in the cancer genome
Abstract: Rho GTPases are believed to make important contributions to the development and progression of human cancer, but direct evidence in the form of somatic mutations analogous to those affecting Ras has been lacking. A recent study in Genes & Development by Xue and colleagues (pp. 1439-1444) now provides in vivo evidence that DLC1, a negative regulator of Rho, is a tumor suppressor gene deleted almost as frequently as p53 in common cancers such as breast, colon, and lung. © 2008 by Cold Spring Harbor Laboratory Press.
Keywords: somatic mutation; gene deletion; review; cancer growth; carcinoma, hepatocellular; liver neoplasms; neoplasms; breast cancer; lung cancer; carcinogenesis; cell transformation, neoplastic; cancer inhibition; tumor suppressor gene; gene expression regulation, neoplastic; colon cancer; tumor suppressor proteins; gtpase-activating proteins; oncogene ras; rho guanine nucleotide binding protein; genes, tumor suppressor; mouse model; rnai; hcc; rhoa; dlc1; dlc1 gene
Journal Title: Genes and Development
Volume: 22
Issue: 13
ISSN: 0890-9369
Publisher: Cold Spring Harbor Laboratory Press  
Date Published: 2008-07-01
Start Page: 1724
End Page: 1730
Language: English
DOI: 10.1101/gad.1691408
PUBMED: 18593873
PROVIDER: scopus
PMCID: PMC2732422
DOI/URL:
Notes: --- - "Cited By (since 1996): 17" - "Export Date: 17 November 2011" - "CODEN: GEDEE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alan Hall
    41 Hall